Primarily, yes. However, principles of leak detection and validation extend to ophthalmic, inhalation, and certain biotech products labeled as sterile.
| Aspect | PDA TR 27 (2014 Rev) | PDA TR 86 (2021) | |--------|----------------------|------------------| | Focus | Fundamental methodology | Emerging challenges & case studies | | Leak size guidance | ≥0.2 µm equivalent | Covers down to sub-micron | | Technologies | Traditional methods | Includes laser-based, microcurrent, and headspace analysis | | Regulatory alignment | Precedes USP <1207> shift | Fully aligned with USP <1207> (2016-on) | | Practical examples | Limited | Extensive industrial case studies | pda technical report 27 pdf
ISO 11607 applies to terminally sterilized medical device packaging. TR 27 covers aseptically filled and terminally sterilized drug products, with greater emphasis on microbial ingress correlation. Primarily, yes
Absolutely not. Draft versions contain unapproved language that could mislead your validation work. Only the final published PDF is acceptable for regulatory purposes. Final Word Whether you are developing a new prefilled syringe, qualifying a blow-fill-seal line, or responding to an FDA audit finding, the PDA Technical Report 27 PDF is an essential compass. Secure your legitimate copy today, integrate its principles into your standard operating procedures, and ensure that your sterile products reach patients exactly as intended—safe, effective, and perfectly sealed. TR 27 covers aseptically filled and terminally sterilized
If you are responsible for sterile packaging, make it a priority to obtain the authentic 2014 revision of TR 27 from PDA. Pair it with TR 86 for current practice, and you will have a complete toolkit for container-closure integrity. Q1: Is the 1998 version of TR 27 still valid? No. Always use the 2014 revision. The 1998 version lacks guidance on probabilistic method validation and modern deterministic technologies.